Phospho-PIN1 (S16) Antibody

What is PIN1 and what is the significance of its phosphorylation at Serine 16?

PIN1 is a peptidyl-prolyl cis/trans isomerase that specifically recognizes and isomerizes phosphorylated Serine/Threonine-Proline bonds in various substrate proteins. Phosphorylation of PIN1 at Serine 16 (S16) in its WW domain is a critical regulatory mechanism that inhibits the ability of PIN1 to bind to its phosphorylated Ser/Thr-Pro targets. This phosphorylation effectively regulates the phosphoserine/threonine-binding activity of the WW domain and consequently modulates PIN1 function . The S16 phosphorylation site serves as a molecular switch controlling PIN1's interaction with its substrates.

How does phosphorylation at S16 affect PIN1's cellular localization and function?

Phosphorylation of PIN1 at S16 significantly alters its subcellular localization. Upon activation of PKA by forskolin treatment, PKA phosphorylates PIN1 at S16, which results in the removal of PIN1 from nuclear speckles and its redistribution throughout the cell . This change in localization directly impacts PIN1's ability to access and isomerize its nuclear substrates. Functionally, this phosphorylation inhibits the ability of the WW domain to bind pSer/Thr-Pro targets, effectively regulating PIN1's isomerase activity and its interaction with substrate proteins .

What are the molecular consequences of PIN1 S16 phosphorylation being disrupted?

When PIN1 S16 phosphorylation is disrupted, as in PIN1 S16A mutant expression, several critical cellular processes are affected. Studies demonstrate that expression of a mutant PIN1 carrying the WW domain S16A mutation (which prevents phosphorylation at this site) induces mitotic block and apoptosis, and increases the formation of multinucleated cells . This evidence strongly indicates that PIN1 phosphorylation at S16 plays an essential role in normal cell cycle progression, and disruption of this regulatory mechanism can lead to cellular dysfunction and potentially oncogenic processes.

What are the optimal conditions for using Phospho-PIN1 (S16) Antibody in Western blotting?

For Western blotting applications, the Phospho-PIN1 (S16) Antibody should be used at a dilution of 1:1000 . Sample preparation should include SDS-PAGE followed by transfer to nitrocellulose membranes (overnight at 200 mA or for at least 2 hours at 50 V). For washing steps, phosphate-buffered saline (PBS) with 0.1% Tween 20 is recommended . Detection can be optimally achieved using HRP-conjugated anti-rabbit secondary antibodies at 1:5000 dilution, followed by enhanced chemiluminescence detection . The antibody has been shown to detect endogenous levels of phosphorylated PIN1 at a molecular weight of approximately 18 kDa .

How can researchers verify the specificity of Phospho-PIN1 (S16) antibody in their experimental system?

To verify antibody specificity, researchers should consider the following multi-faceted approach:

• Positive and negative controls: Include samples with known PIN1 phosphorylation status, such as cells treated with PKA activators (positive control) and PIN1 knockdown cells (negative control).

• Phosphatase treatment: Treat half of your sample with lambda phosphatase to remove phosphorylation and confirm the signal disappears.

• Mutagenesis validation: Use cells expressing PIN1 S16A mutant to confirm absence of signal with the phospho-specific antibody.

• Stimulation experiments: Treat cells with known modulators of PIN1 phosphorylation, such as TPA or forskolin, which should increase S16 phosphorylation .

• Knockdown/knockout validation: Use shRNA-mediated PIN1 knockdown to confirm reduction in both total and phosphorylated PIN1 signal .

What experimental approaches can be used to study the functional consequences of PIN1 S16 phosphorylation?

Several experimental approaches can be utilized to investigate the functional impact of PIN1 S16 phosphorylation:

• Site-directed mutagenesis: Generate S16A (phospho-deficient) or S16D/E (phospho-mimetic) PIN1 mutants and express them in cellular models to observe phenotypic consequences on cell cycle, apoptosis, and multinucleation .

• Subcellular localization studies: Use immunofluorescence with Phospho-PIN1 (S16) antibody or fluorescently-tagged PIN1 constructs to track localization changes upon treatments that modulate S16 phosphorylation.

• GST pull-down assays: Compare binding affinities of wild-type and mutant PIN1 to substrate proteins to assess how S16 phosphorylation affects target interactions .

• In vitro isomerization assays: Measure the isomerase activity of phosphorylated versus non-phosphorylated PIN1 using synthetic peptide substrates.

• Proximity ligation assays: Detect in situ interactions between PIN1 and its substrates under conditions that promote or inhibit S16 phosphorylation.

How does PIN1 function in TNF-α signaling pathways, and how can researchers investigate this role?

PIN1 acts as a molecular switch in TNF-α signaling, particularly in neutrophils. PIN1 is expressed in neutrophil cytosol, and its activity is markedly enhanced by TNF-α stimulation . To investigate this role, researchers can:

• Measure ROS production: Assess N-formyl-methionyl-leucyl-phenylalanine peptide (fMLF)-induced reactive oxygen species production after TNF-α priming, with or without PIN1 inhibitors like juglone .

• Translocation assays: Monitor PIN1 and p47phox translocation to membranes following TNF-α and fMLF treatment through subcellular fractionation and Western blotting .

• Interaction studies: Perform GST pull-down assays to investigate PIN1 binding to p47phox via phosphorylated Ser345, using the following protocol:

  • Incubate 1 μg each of GST-Pin1 and p47phox with glutathione-Sepharose beads

  • Use interaction buffer containing PBS, 1% CHAPS, 0.1mM DTT, 5mM NaF, and 1mM β-glycerophosphate

  • Incubate for 2 hours, wash, then cleave with thrombin protease

  • Analyze by SDS-PAGE and Western blot with specific antibodies

• Phosphorylation analysis: Examine how PIN1 facilitates p47phox phosphorylation by PKC using phospho-specific antibodies against Ser315, Ser320, and Ser328 .

What is the role of PIN1 in oncogene-induced senescence, and how can Phospho-PIN1 (S16) Antibody help study this process?

PIN1 functions as a key regulator in oncogene-induced senescence (OIS), with evidence suggesting it acts as a tumor suppressor in response to oncogenic RAS activation . Studies have shown that:

• PIN1 protein levels increase approximately two-fold in senescent cells after 4 days of 4-OHT treatment in IMR90-ER:Ras G12V cells .

• PIN1 knockdown promotes cell proliferation while diminishing senescence phenotypes, including reduction in p21, p16, and p53 levels .

• PIN1 regulates several promyelocytic leukemia nuclear body (PML-NB) proteins, specifically in response to oncogenic Ras activation .

Researchers can use Phospho-PIN1 (S16) Antibody to:

• Monitor PIN1 phosphorylation status during OIS progression

• Examine how PIN1 phosphorylation correlates with its tumor suppressor function

• Investigate the relationship between PIN1 phosphorylation and interaction with senescence mediators like p53

• Compare phosphorylation patterns in normal versus oncogene-expressing cells

How does PIN1 S16 phosphorylation status differ across cancer types, and what methodological approaches can be used to profile this variation?

PIN1 is overexpressed in many types of cancer and plays roles in various oncogenic pathways . To profile S16 phosphorylation across cancer types, researchers can employ these methodological approaches:

• Tissue microarray analysis: Use Phospho-PIN1 (S16) Antibody for immunohistochemistry on multi-cancer tissue arrays to compare phosphorylation levels across tumor types.

• Quantitative Western blotting: Compare the ratio of phosphorylated to total PIN1 across cancer cell lines using densitometry analysis:

• Phosphoproteomics: Perform LC-MS/MS analysis of cancer tissues to identify PIN1 phosphopeptides and quantify S16 phosphorylation states.

• Correlation with kinase activity: Profile activities of kinases known to phosphorylate PIN1 (PKA, RSK2) across cancer types to identify potential regulatory mechanisms.

How can researchers investigate the structural changes in PIN1 induced by S16 phosphorylation?

To investigate structural changes in PIN1 induced by S16 phosphorylation, researchers can employ these advanced techniques:

• X-ray crystallography: Crystallize phosphorylated and non-phosphorylated forms of PIN1 to determine atomic-level structural differences.

• NMR spectroscopy: Use solution NMR to examine conformational changes and dynamics between phosphorylated and non-phosphorylated states.

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Compare solvent accessibility changes between phosphorylated and non-phosphorylated PIN1 to identify regions undergoing conformational changes.

• FRET-based sensors: Design fluorescent biosensors with PIN1 domains to monitor conformational changes upon S16 phosphorylation in real-time in living cells.

• Molecular dynamics simulations: Perform computational analysis of how S16 phosphorylation affects PIN1 structure, flexibility, and interaction surfaces.

What are the best approaches for studying the kinetics of PIN1 S16 phosphorylation and dephosphorylation in response to cellular stimuli?

To study the kinetics of PIN1 S16 phosphorylation and dephosphorylation, researchers should consider these methodological approaches:

• Time-course experiments: Treat cells with stimuli known to induce PIN1 phosphorylation (e.g., forskolin, TPA) and collect samples at multiple time points for Western blot analysis with Phospho-PIN1 (S16) Antibody.

• Pulse-chase analysis: Use phosphate labeling with 32P followed by immunoprecipitation to track phosphorylation and dephosphorylation rates.

• Phosphatase inhibitor studies: Use specific inhibitors to identify which phosphatases regulate PIN1 S16 dephosphorylation.

• In vitro kinase assays: Reconstitute phosphorylation reactions using purified PIN1 and candidate kinases (PKA, RSK2) to determine kinetic parameters.

• Phospho-flow cytometry: Develop protocols using Phospho-PIN1 (S16) Antibody for single-cell analysis of phosphorylation kinetics within heterogeneous populations.

How can researchers develop efficient PIN1 S16 phosphorylation-specific inhibitor screening assays?

To develop screening assays for compounds that specifically modulate PIN1 S16 phosphorylation, researchers can implement these approaches:

• ELISA-based high-throughput screening:

  • Coat plates with PIN1 substrate

  • Add recombinant PIN1 (wild-type or S16A) and test compounds

  • Detect isomerization using conformation-specific antibodies

  • Compare effects on wild-type versus S16A PIN1 to identify S16 phosphorylation-dependent inhibitors

• Cellular reporter systems:

  • Develop split luciferase complementation assays where luciferase fragments are fused to PIN1 and a substrate

  • Signal generation depends on PIN1-substrate interaction, which is regulated by S16 phosphorylation

  • Screen compounds in cells expressing this reporter system

• Phosphorylation-specific Western blot screening:

  • Treat cells with compound libraries in multiwell format

  • Use automated Western blotting to detect changes in PIN1 S16 phosphorylation levels

  • Calculate phospho/total PIN1 ratios to identify modulators

• In silico screening:

  • Use structural data of phosphorylated versus non-phosphorylated PIN1

  • Perform virtual screening to identify compounds that stabilize either state

  • Validate hits with biochemical and cellular assays

What are common pitfalls when working with Phospho-PIN1 (S16) Antibody, and how can researchers overcome them?

When working with Phospho-PIN1 (S16) Antibody, researchers may encounter these challenges:

• High background signal:

  • Solution: Optimize blocking conditions (try 5% BSA instead of milk)

  • Increase washing steps (5×5 minutes with PBS-T)

  • Pre-absorb antibody with non-specific proteins

  • Ensure proper dilution (1:1000 recommended)

• Loss of phosphorylation during sample preparation:

  • Solution: Add phosphatase inhibitors (5mM NaF, 1mM β-glycerophosphate) to all buffers

  • Keep samples cold throughout preparation

  • Use rapid lysis techniques to preserve phosphorylation status

• Cross-reactivity issues:

  • Solution: Validate specificity using S16A mutant controls

  • Use phosphatase-treated samples as negative controls

  • Consider pre-clearing antibody with non-specific proteins

• Variable results across experiments:

  • Solution: Standardize cell culture conditions

  • Use internal loading controls rigorously

  • Normalize phospho-signal to total PIN1 levels

  • Ensure consistent timing of treatments and lysis

How can researchers develop effective protocols for studying PIN1 S16 phosphorylation in diverse tissue types?

To optimize protocols for studying PIN1 S16 phosphorylation across different tissue types, researchers should consider:

• Tissue-specific extraction protocols:

  • Brain tissue: Use specialized lysis buffers containing 1% Triton X-100, 0.1% SDS

  • Muscle tissue: Include higher protease inhibitor concentrations and mechanical disruption

  • Adipose tissue: Add defatting steps before protein extraction

  • Fibrotic tissues: Consider additional sonication or homogenization steps

• Phosphorylation preservation strategies:

  • Flash-freeze tissues immediately in liquid nitrogen

  • Include heat-stable phosphatase inhibitors in all buffers

  • Consider pre-treating animals with phosphatase inhibitors before tissue collection

  • Optimize tissue disruption to minimize time before protein denaturation

• Detection optimization:

  • Adjust primary antibody incubation time (overnight at 4°C often optimal)

  • Consider signal amplification systems for low-abundance tissues

  • Test alternative blocking reagents for tissues with high background

  • For immunohistochemistry, compare antigen retrieval methods

• Validation across tissue types:

  • Generate tissue-specific positive controls using phosphorylation-inducing treatments

  • Compare results from multiple antibody lots

  • Verify with alternative methods (MS-based phosphoproteomics)

What are the most effective strategies for correlating PIN1 S16 phosphorylation with isomerase activity in complex biological samples?

To correlate PIN1 S16 phosphorylation status with its isomerase activity in biological samples, researchers can implement these effective strategies:

• Sequential immunoprecipitation and activity assay:

  • Immunoprecipitate total PIN1 from biological samples

  • Split the sample for parallel analysis:
    a) Western blot with Phospho-PIN1 (S16) Antibody to quantify phosphorylation
    b) Isomerase activity assay using peptide substrates with proline in cis/trans configurations

  • Correlate phosphorylation levels with activity measurements

• In situ isomerization analysis:

  • Develop cellular reporters with PIN1 substrates that produce signals upon isomerization

  • Simultaneously monitor S16 phosphorylation by immunofluorescence

  • Quantify correlations at single-cell level

• Phosphomimetic comparisons:

  • Express wild-type, S16A, and S16D/E PIN1 variants in cells lacking endogenous PIN1

  • Measure isomerase activity toward various substrates

  • Create activity profiles for each phosphorylation state

• Temporal analysis during signaling events:

  • Track both S16 phosphorylation and isomerase activity at multiple timepoints after stimulation

  • Generate time-resolved correlation plots between phosphorylation and activity

  • Identify time lags that might indicate additional regulatory steps

This systematic approach allows researchers to establish mechanistic links between PIN1 S16 phosphorylation and functional outcomes in diverse biological contexts.